Comparative Study of Nebivolol versus Atenolol in the Treatment of Mild and Moderate Essential Hypertension
نویسنده
چکیده
Nebivolol, β1 selective drug is a third generation β blocker with nitric oxide donating antiproliferative and antioxidant properties which are useful to maintain a proper metabolic profile compared to atenolol, a β1 selective drug most commonly used. A prospective randomized parallel double blind study was conducted in patients with essential hypertension. Group A received nebivolol and group B received atenolol for 12 weeks. Baseline investigations were carried out before and after the study. The data was statistically analysed using students ‘T’ test. Both atenolol and nebovolol showed significant reduction in both systolic blood pressure and diastolic blood pressure (P<0.001) after 12 weeks. Heart rate was significantly reduced (P<0.001) in the group that received atenolol. Blood sugar was significantly increased (P<0.001) in atenolol group after 12 weeks. It was concluded that nebivolol was better than atenolol in terms of improvement in blood sugar and heart rate.
منابع مشابه
Nebivolol in the management of essential hypertension: a review.
UNLABELLED Nebivolol is a lipophilic beta1-blocker. It is devoid of intrinsic sympathomimetic or membrane stabilising activity but appears to have nitric oxide-mediated vasodilatory effects. Nebivolol is administered as a racemic mixture of equal proportions of d- and l-enantiomers. The drug does not significantly influence glucose or plasma lipid metabolism and appears to have a protective eff...
متن کاملTHE COMPARATIVE STUDY OF ANTIHYPERTENSIVE TREATMENTS (CSAT): BACKGROUNDS, METHODS, AND THE PRELIMINARY RESULTS (INTERIM REPORT)
The "Comparative Study of Antihypertensive Treatments"-CSA T is a placebo-controlled, randomized, double-blind clinical trial, with the primary objective of comparing the efficacy of different pharmacological treatments of hypertension. Drug side-effects, patient compliance, and alterations in the patients' quality of life are also compared. Subjects with mild to moderate diastolic hyperte...
متن کاملBeneficial effects of switching from beta-blockers to nebivolol on the erectile function of hypertensive patients.
AIM To investigate the effect of substituting beta-blockers with nebivolol on the erectile function of patients suffering from essential hypertension. METHODS Forty-four young and middle-aged men (31-65 years) with essential hypertension visited our outpatient clinic and took beta-blocker treatment (atenolol, metoprolol or bisoprolol) for more than 6 months. All the patients completed a quest...
متن کاملNebivolol reverses endothelial dysfunction in essential hypertension: a randomized, double-blind, crossover study.
BACKGROUND Vascular endothelial dysfunction may predict future atherosclerosis. Hence, an antihypertensive agent that reverses endothelial dysfunction and lowers blood pressure might improve the prognosis of patients with hypertension. We hypothesized that nebivolol, a vasodilating beta-blocker, could improve endothelial dysfunction. We tested this hypothesis by comparing the effects of nebivol...
متن کاملLeft ventricular mass and mechanics in mild-to-moderate hypertension: effect of nebivolol versus telmisartan.
BACKGROUND The aim of this study was to compare the effects of nebivolol and telmisartan on left ventricular mass (LVM) and midwall mechanics in mild-to-moderate hypertension. METHODS A total of 40 patients with mild-to-moderate hypertension were randomized to receive either nebivolol (2.5 to 5.0 mg/day) or telmisartan (40 to 80 mg/day) to achieve a target diastolic blood pressure of <90 mm H...
متن کامل